|
Level of
Care Model
Given that Tobacco
use
prevention
and
cessation (TUPAC)
in the dental
treatment setting
occurs in brief
interventions
over repeated
visits, dental
practitioners
should consider
adopting the
following
level of
care model.
Basic Care:
brief interventions
of a few
minutes
in order
to identify
tobacco
users, assess
readiness
to quit,
request
permission
to re-address
tobacco
use at a
subsequent
visit, and
if preferred,
refer for
further
TUPAC counselling.
Intermediate
Care:
interventions
of 5 to
10 or more
minutes
consisting
of (brief)
motivational
interviewing
sessions
to build
on readiness
to quit,
enlist resources
to support
change,
and to include
cessation
medications.
If
preferred,
refer for
further
TUPAC counselling.
Advanced
Care:
multiple
intensive
interventions
of 20 or
more minutes
for complex
care patients
to develop
a detailed
quit plan
including
the use
of suitable
pharmacotherapy,
past failure
exploration,
and recommendation
adjustments
as needed.
The level of care
model
was originally
published by
Davis et al.
2010
and summarized
in the 2nd OHNTPC
European Workshop
Consensus Report
by
Ramseier et
al. 2010.
Basic Care:
tobacco use
brief interventions
Ask
Ask
all
patients
aged
16 years and
over (younger
if appropriate):
“Do
you use tobacco?”
It is well recognized
that the medical
history form
plays a critical
role in developing
an oral health
care plan that
is cognisant
of the general
health status.
The inclusion
of the patients’
tobacco use
history is shown
to be a vital
component of
the medical
history form
on a myriad
of levels that
are integral
to the promotion
of tobacco use
prevention and
cessation.
For
example, if
the patient
identifies as
a never-smoker,
it enables the
oral health
professional
to reinforce
the benefits
of this lifestyle
choice.
Particularly
in the case
of young adults,
the opportunity
to congratulate
their decision
to remain tobacco
free offers
a positive counter
to the efforts
of peer pressure,
advertising
or other adverse
influence. Should
the patient
identify as
a former smoker,
the opportunity
arises again
to provide positive
reinforcement
to the decision
to change.
Assess
With
all tobacco
users assess
readiness to
quit:
“Are
you interested
in stopping?”
When asked about
their readiness
to quit smoking,
tobacco users
often reply
that they want
to quit smoking
"sometime" but
that the time
is not yet right.
There are certain
things they
need to do first,
which are seen
as more important
than giving
up smoking.
Even if the
patient feels
that they are
ready to quit
smoking, there
still may be
some uncertainty
about the next
steps. They
may experience
a lack
self-efficacy
to achieve this
goal and feel
under prepared
to make a quit
attempt. Behind
this attitude
is often the
fear of failure,
potential change
to social habits,
or worry about
gaining unwanted
weight.
(Brief) Motivational
Interviewing,
(B)MI
Numerous
behavioral
studies have
demonstrated
predictable
success in supporting
patients to
change using
Motivational
Interviewing
(MI). MI is
a patient-centred
method to enhance
the patient’s
intrinsic motivation
to change by
exploring and
resolving ambivalence
(Miller and
Rollnick 2002).
A "short form"
of MI known
as "Brief Motivational
Interviewing"
(BMI) appears
to be suitable
for use during
short interventions
for tobacco
use prevention
and cessation
in dental practices.
The aim of BMI
is to achieve
the following
objectives within
a relative short
amount of time:
-
to ask the
patient
about his
or her motivation
to change,
-
to
ask
the patient’s
self-efficacy
to change,
and
-
to get the
patient’s
commitment
to discuss
the change
in
behavior
at the next
visit.
Understanding
the current
levels of recognized
motivation
and
self-efficacy
as
indicators of
the readiness
to change can
greatly assist
the process
of supporting
the patient
through a quit
attempt
(Rollnick et
al. 1997).

For example,
asking the
patient to
use a number
scale to
rate how
motivated he
or she
is to quit smoking
will give a
direction for
the oral health
professional
to follow. Using
the same number
scale to rate
how confident
they are in
achieving this
goal will further
direct the conversation
towards identifying
the type of
support the
patient may
need.
Intermediate
Care:
behavior
support
for tobacco use
cessation
Assist
Providing assistance
for the patient
who wants to
quit using tobacco
often requires
a combination
of behavioral
modification
techniques and
pharmacological
support. Making
arrangements
for on-going
support either
via the dental
office or other
health agencies
provides the
patient with
a valuable sense
of reassurance
as they undertake
a quit attempt.
“How
would you like
to stop?”
When
available, refer
to TUPAC specialist
service, whether
in-house (including
suitably trained
dental personnel)
or external
(i.e.
www.quitline.com)
If no TUPAC
specialist service
is available
or patient declines
referral
consider to
offer
behavioral
support and
pharmacotherapy
as outlined
in the
following
step-by-step
protocol.
Assist:
Step-by-step
protocol
People who want
to kick the
smoking habit
do not always
participate
in carefully
controlled nicotine
withdrawal programs,
e.g. in linear
fashion and
from start to
finish. Nevertheless,
simple instructions
– like those
offered in the
"Assist" (to
help) and "Arrange"
(to organize
follow-up visits)
– can be valuable
tools for dental
professionals
supporting their
patients to
quit smoking.
Some smokers
may even be
euphoric about
quitting smoking
that would therefore
tend to quit
in a premature
– e.g. unprepared
– manner. Even
if this approach
works for some
smokers, others
require varying
amounts of support.
This support
can be given
in an individual
way manner by
adapting the
following
four steps:
Step 1: Ask
the patient
to fill in the
tobacco use
journal
Every smoker
has his or her
individual smoking
habits. To pinpoint
the behavioral
changes required
in each particular
case, it is
recommended
to fill in a
tobacco use
journal for
several days.
The patient
will be instructed
to fill in every
column in the
jornal.

-
Instructions
for the
period up
to the patient's
next appointment:
Fill in
each cigarette
and the
time it
is smoked;
again, be
sure to
fill in
all four
columns
of the journal
labelled
as “Time”,
“Place or
activity”,
“Companion”,
“Importance”,
and “Alternative”.
Step
2:
Evaluate
the tobacco
use journal
Reading through
the journal
entries at the
follow-up appointment
may reveal patterns
of smoking and
assessments
of importance
which may not
have been aware
to the patient.
This information
will serve as
the basis for
re-assigning
new habits for
the patient
in order to
give up smoking
(ideally without
withdrawal symptoms)
and to replace
the old habit
with new patterns
of behavior.
During this
period, the
patient will
be advised to
reduce tobacco
use to a bearable
minimum.
The four columns
of the journal
contain information
on four important
elements of
the cessation
protocol:
-
"Time":
Patients
who smoke
regularly
throughout
the day
are primarily
advised
to alleviate
the physical
symptoms
of withdrawal
with sustained-release
nicotine
patches.
On the other
hand, patients
who only
smoke at
certain
times
throughout
the day
are generally
advised
to use nicotine
gum, sublingual
tablets
or lozenges.
The smoking
behavior
that has
been evaluated
can be entered
later in
the form
labelled
"Recommendations
for Use
of Nicotine
Replacement
Therapy"
(see below).
-
"Place
or Activity"
and "Companion":
Instructions
for the
period up
to the patient's
next appointment:
Attempt
to change
situations.
Example:
Spend your
work break
with different
colleagues
and at a
different
location
than usual.
-
"Importance":
Instructions
for the
period up
to the patient's
next appointment:
Try to reduce
the number
of "less
important"
cigarettes.
-
"Alternative":
Instructions
for the
period up
to the patient's
next appointment:
The patient
should try
to find
his or her
own personal
alternatives
– so-called
replacements
– which
could help
them to
resist.
In this
context,
they should
take care
to alternatively
distract
their mind
(mental),
their hands
(physical)
and their
mouths (oral).
Examples:
Play a game
that requires
mental concentration
or manual
dexterity.
Do not select
alternatives
that simulate
smoking.
Example:
chewing
on a stick
of liquorice.
Step
3: Behavioral
changes and
nicotine dependence
The process
of successfully
replacing smoking
habits with
other activities
can be difficult
and time-consuming.
Each patient
should identify
replacements
(see above)
that contain
a personal reward.
It might be
wise to schedule
and arrange
additional consultation
time as this
point so that
enough emphasis
can be devoted
to this important
step.
-
"Have you
already
attempted
to give
up smoking?"
-
"How many
cigarettes
do you smoke
a day?"
-
"How many
minutes
after waking-up
in the morning
do you smoke
your first
cigarette?"
On the basis
of the answers
to these questions,
the patients
can be divided
into four groups:
very high dependence,
high depende,
medium dependent
and low dependence.
The answer showing
the greatest
dependency indicates
the overall
dependency.
Step
4:
Set the
Quit
Date
On the quit
date, ideally,
the patient
will be released
from the dental
practice as
a former smoker.
It may be worthwhile
to give each
individual patient
a written recommendation
for the use
of nicotine
replacement
therapy for
the following
three months.
-
Confirm
or redefine
the replacements
that have
been identified.
-
Give the
patient
a written
recommendation
on nicotine
replacement
therapy
on the basis
of both
his or her
smoking
behavior
and degree
of nicotine
dependence.
Arrange
Experience reveals
that smokers
have to make
several attempts
to quit smoking
before staying
a former smoker.
Of the patients
who initially
succeed in kicking
the habit, 50%
- 60% will suffer
a relapse within
the next year.
Even though
there are at
present no evidence-based
methods for
preventing relapses,
the dental practice
team can continue
to offer support
during their
patients' repeated
attempts to
quit smoking.
Alternatively,
the patients
can be referred
at this time
to tobacco use
cessation specialists,
their family
doctors, pharmacists
or psychotherapists.
Intermediate
Care:
pharmacotherapy
for tobacco
use
cessation
Nicotine
replacement
therapy (NRT)
The symptoms
of nicotine
withdrawal can
substantially
hamper a person's
success to quit
smoking. The
most common
symptoms of
nicotine withdrawal
are reported
to be headache,
gastrointestinal
complaints,
sleeping disorders,
depression and
increased appetite.
Withdrawal usually
occurs shortly
after the person
has smoked his
or her last
cigarette and
occasionally
lasts for several
days or a few
weeks. Withdrawal
symptoms can
be significantly
reduced by pharmacotherapy
e.g. with the
replacement
of nicotine.
It can help
former smokers
to resist their
withdrawal symptoms
and to carry
out the replacements
instead as planned.
Nicotine replacement
therapy (NRT)
is shown to
increase success
rates by roughly
100%. Additionally,
research on
NRT consistently
revealed that
comparable success
rates were achieved
with the use
of nicotine
gum, nicotine
sublingual tablets
or lozenges,
or nicotine
patches.
If there are
no medical contraindications
for the patient,
NRT products
can be used
without restrictions.
Nevertheless,
some reservations
remain for pregnant
women and patients
with cardiovascular
conditions.
Literature suggests,
however, that
the benefits
of NRT for smoking
cessation may
outweigh the
detrimental
effects from
the continued
use of tobacco.
Significant
success rates
from the use
of NRT will
be achieved
when the appropriate
product is selected
adjusted to
-
the degree
of nicotine
dependency
and
-
the individual
smoking
behavior
(see
Table
above).
In general,
patients
with "high"
or "very
high"
nicotine
dependence
are advised
to take
combinations
of NRT.
Furthermore,
NRT should
be used
for the
entire duration
of the therapy
(3 months),
while the
nicotine
dose will
be reduced
every month
as suggested
by the manufacturer.
Bupropion SR
Sustained-release
Bupropion
(Bupropion
SR) is a
non-nicotine-containing
drug used
for tobacco
use
cessation
therapy
(Zyban®,
Wellbutrin®,
GlaxoSmithKline,
USA). With
Bupropion,
the neuronal
uptake of
catecholamines
will
be selectively
inhibited
in the
central
nervous
system.
Consequently,
catecholamine
levels will
increase in
certain
areas of the
brain
resulting in
the
reduction of
nicotine
withdrawal
symptoms.
The
manufacturer
recommends
that
Bupropion SR
is prescribed
for the
duration of
seven weeks.
In order to
reach
therapeutic
levels,
Bupropion SR
will have to
be taken for
two weeks.
Tobacco use
should be
ceased only
after
therapeutic
levels have
been
established.
During the
first week,
it is
recommended
that 150mg of
Bupropion SR
is taken per
day. After
one week,
150mg will
be taken
twice daily
for the
duration of
six weeks.
The efficacy
of Bupropion
SR either
alone or in
in
combination
with
other nicotine
replacement
therapy
options was
evaluated
with
non-depressed
cigarette
smokers in
placebo-controlled
double-blind
trials (Holm
& Spencer
2000). The
abstinence
rates for
the use of
Bupropion SR
alone was
23.1%
following 12
months after
the quit
date (Hurt
et al.
1997), and
35.5%
following 12
months when
Bupropion SR
was used in
combination
with
nicotine
replacement
therapy
(Jorenby et
al. 1999).
The most
common side
effects of
Bupropion
have been
described as
insomnia,
headaches,
and dry
mouth. Prior
to
prescription,
it has to be
noted that
the
simultaneous
use of
psychotropic
drugs or
cortisone
should be
avoided.
Further
contraindications
exist in
patients
with a
history of
bulimia,
anorexia
nervosa, and
in
those who
experience epilepsy.
Pregnant
women are to
be advised
not to take
Bupropion
SR, since
its safety
during
pregnancy
has not been
studied in
clinical
trials.
Varenicline
Varenicline
has been
specifically
developed
for smoking
cessation
therapy
(Chantix®,
Champix®,
Pfizer Inc.,
USA).
Varenicline
connects as
a partial
agonist with
a high
affinity to
the
α4β2-nicotinic
acetylcholine
receptors in
the central
nervous
system.
Subsequently,
the binding
of nicotine
will be
blocked
resulting in
the
elimination
of its
addictive
effect.
Additionally,
the binding
of
Varenicline
sufficiently
reduces the
symptoms of
craving and
withdrawal
(Coe et al.
2005,
Keating &
Siddiqui
2006).
Varenicline
prescription
is
recommended for
a duration of
three months
and may be
extended if
necessary by
a subsequent three
months. In
order to
reach
therapeutic
blood plasma
levels, 1mg
of
Varenicline
will be
taken per
day for
the duration
of one week.
Only
thereafter,
tobacco use
should be
ceased.
After one
week, 1mg
will be
taken twice
daily for
the duration
of 11 weeks.
Five
clinical
studies
involving a
total of
aproximally 4300
patients,
mostly
heavy,
long-term
smokers have
shown
significantly
greater success rate
following
one year
after quit
date with
Varenicline
(14.4 - 23%)
(Gonzales et
al. 2006,
Jorenby et
al., 2006,
Nides et
al., 2006)
and placebo
(3.9 -
10.3.%)
(Oncken et
al., 2006).
When taking
Varenicline
for the
duration of
six months,
one-year
success
rates of
43.6% have
been reached
(Tonstad et
al., 2006).
The most
common side
effects of
Varenicline
include
dizziness,
insomnia,
indigestion
and
vomiting.
Patients
with renal
insufficiency
and
pregnancy
are not
recommended
for
treatment
with
Varenicline.
|
References
Davis, J. M., Ramseier, C. A., Mattheos,
N., Schoonheim-Klein, M., Compton, S., Al-Hazmi, N.,
Polychronopoulou, A., Suvan, J., Antohe, M. E., Forna, D.
& Radley, N. (2010) Education of tobacco use prevention
and cessation for dental professionals--a paradigm shift.
Int Dent J 60, 60-72.
Ramseier, C. A., Warnakulasuriya, S.,
Needleman, I. G., Gallagher, J. E., Lahtinen, A.
et al. (2010) Consensus report: 2nd European
workshop on tobacco use prevention and cessation
for oral health professionals. Int Dent J 60, 3-6.
Ramseier, C. A. & Fundak, A. (2009)
Tobacco use cessation provided by dental
hygienists. Int J Dent Hyg 7, 39-48.
Rollnick, S., Butler, C. C. & Stott,
N. (1997) Helping smokers make decisions: the
enhancement of brief intervention for general
medical practice. Patient Educ Couns 31, 191-203.
Miller, W. R. & Rollnick, S.
(2002). Motivational Interviewing: Guilford Press, New
York.
Fagerstrom, K. O. (1978) Measuring
degree of physical dependence to tobacco smoking
with reference to individualization of treatment.
Addict Behav 3, 235-241.
|
Clinical
Practice
Guidelines "Tobacco use
and Dependence"
Please consider
as well the
clinical practice
guideline "Treating
Tobacco use
and Dependence"
by Fiore
et al. 2008
as a
reference.
|
Reference
Fiore MC, Jaén CR, Baker TB, et al.
Treating tobacco use and dependence: 2008 update.
Clinical practice guideline. Rockville, MD: U.S.
Department of Health and Human Services. Public
Health Service, 2008.
|
Tobacco
Use
Cessation
Care Pathway
for the
Dental
Practice
At the first
European Workshop
of Tobacco use
Prevention and
Cessation for
Oral Health
Professionals
in 2005, the
following care
pathway has
been defined.

You may want
to download
and print the
'05 workshop
care pathway,
courtesy provided
from the Quitessence
Publishing Group:
|
References
Ramseier, C. A., Mattheos, N.,
Needleman, I., Watt, R. & Wickholm, S. (2006)
Consensus report: First European Workshop on Tobacco
Use Prevention and Cessation for Oral Health
Professionals. Oral Health Prev Dent 4, 7-18.
Needleman, I., Warnakulasuriya, S.,
Sutherland, G., Bornstein, M. M., Casals, E.,
Dietrich, T. & Suvan, J. (2006) Evaluation of
tobacco use cessation (TUC) counselling in the
dental office. Oral Health Prev Dent 4, 27-47.
|
|